A Phase 2/3 interventional study of Smoking cessation treatment plus moderate intensity exercise and Smoking cessation treatment plus health education in Lung Cancer, Heart Disease and COPD, sponsored by The Miriam Hospital. Completed at 1 site in United States. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-14.
Sponsored by The Miriam Hospital · Phase 2/3, Interventional, and Prevention
This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy women. We hypothesize that participants in the smoking cessation plus moderate intensity exercise condition will be more likely to quit smoking than participants in the smoking cessation treament plus contact control condition.
This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy women. A number of techniques will be used to increase compliance with the treatment program, thus more effectively isolating the effects of exercise. These include: (1) a two-week run-in period prior to randomization; (2) use of behavioral contracting prior to participant randomization; and (3) performance of all exercise on-site. Smoking cessation outcomes (continuous abstinence and point prevalence abstinence) will be verified by carbon monoxide and saliva cotinine. Physical activity will be evaluated by attendance at the supervised sessions. We hypothesize that participants in the smoking cessation plus moderate intensity exercise condition will be more likely to quit smoking than participants in the smoking cessation treament plus contact control condition.
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's enrollment of 59 is below the median of 100 across 1,778 interventional studies indexed under Heart Diseases.
Browse Heart Diseases studies →The Miriam Hospital is the lead sponsor of 178 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Acebutolol Atenolol Carvedilol Metoprolol Nadolol Pindolol Propranolol Timolol
Medical problems:
Psychiatric Problems
REQUIRES MD CONSENT FOR THE SPECIFIC CONDITION
3x/wk 50 minutes of moderate intensity walking on treadmills + health education videos
Behavioral: Smoking cessation treatment plus moderate intensity exercise
Contact control group attending 3x/wk 50 minutes of health education videos
Behavioral: Smoking cessation treatment plus health education
7-day point prevalence smoking abstinence verified by saliva cotinine taken
Time frame: post-intervention (8 weeks after baseline)
7-day point prevalence smoking abstinence verified by saliva cotinine
Time frame: taken one month post-intervention (12 weeks after baseline)
This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Miriam Hospital